# Small-molecule APIs: Trading

How India set price floors against cheap Chinese antibiotics

Source page: https://www.materialinsights.org/chemicals/apis/trading/

What this tab covers How it is bought and sold: buyers and sellers, price benchmarks and who publishes them, exchanges, contract types, traders, how Indian buyers price it, recent price points, and good sources to follow.

#### Who buys, and where

- China (KSMs, fermentation APIs, commodity APIs)
- India (regulated-market generic APIs)
- Europe (complex and controlled APIs)

#### Who sells, and from where

- US and EU generic formulators
- India's domestic formulators
- Africa, Latin America and global health tenders

#### Price benchmarks

| Benchmark | Publisher | Basis |
|---|---|---|
| **Pharmaoffer API transaction averages** | Pharmaoffer | 12-month and 90-day averages from shipment records |
| **IMARC and ChemAnalyst quarterly API price reports** | IMARC, ChemAnalyst | assessed, quarterly |

#### Contract types

- Annual or multi-year supply agreements tied to DMF references
- Spot purchase orders for generics
- Long-term supply agreements for innovators (Divi's had three in validation in Q4 FY26)

#### Traders and distributors

- Not dominated by traders; sourcing agents and distributors handle small buyers

#### How Indian buyers price it

- Import parity from China (CIF plus customs duty)
- Minimum import prices on penicillin G, 6-APA, amoxicillin (DGFT, Jan 2026, one year)
- Finished drug ceiling prices set by NPPA under DPCO 2013, which caps how much API cost formulators can pass on

#### Recent price points

| Date | Price | Basis | Source |
|---|---|---|---|
| Q2 2025 | **$2,958/t paracetamol** | India | IMARC (2025) |
| Jan 2026 | **Rs 2,216/kg penicillin G potassium (MIP)** | CIF India floor | Medical Dialogues (Jan 2026) |

#### Good sources to follow
[Pharmaoffer API price and transactions](https://pharmaoffer.com/api-excipient-supplier/transactions/paracetamol)freemium research site · Pharmaoffer

API transaction prices and trade flows by molecule
[DCAT Value Chain Insights](https://www.dcatvci.org/)free newsletter · Drug, Chemical and Associated Technologies Association

API and CDMO industry news and analysis
[Indian Pharma Post](https://www.indianpharmapost.com/)free newsletter · Indian Pharma Post

Indian API and pharma company results
[BioSpectrum India](https://www.biospectrumindia.com/)free newsletter · MM Activ

Indian pharma and API self-reliance coverage

## Other sections

- [Summary](https://www.materialinsights.org/chemicals/apis/index.md)
- [Overview](https://www.materialinsights.org/chemicals/apis/overview/index.md)
- [Correlation](https://www.materialinsights.org/chemicals/apis/correlation/index.md)
- [Production route](https://www.materialinsights.org/chemicals/apis/routes/index.md)
- [Production](https://www.materialinsights.org/chemicals/apis/production/index.md)
- [Feedstocks](https://www.materialinsights.org/chemicals/apis/feedstocks/index.md)
- [Cycles](https://www.materialinsights.org/chemicals/apis/cycles/index.md)
- [Movement](https://www.materialinsights.org/chemicals/apis/movement/index.md)
- [Regulation](https://www.materialinsights.org/chemicals/apis/regulation/index.md)
- [Characteristics](https://www.materialinsights.org/chemicals/apis/characteristics/index.md)
- [Emissions](https://www.materialinsights.org/chemicals/apis/emissions/index.md)
- [Relationships](https://www.materialinsights.org/chemicals/apis/links/index.md)